|
|
Previous Article | Table of Contents | Next Article 
Blood, Vol. 94 No. 2 (July 15), 1999:
pp. 701-712
Reactive Plasmacytoses Are Expansions of Plasmablasts Retaining the
Capacity to Differentiate Into Plasma Cells
Gaëtan Jego,
Nelly Robillard,
Denis Puthier,
Martine Amiot,
Françoise Accard,
Danielle Pineau,
Jean-Luc Harousseau,
Régis Bataille, and
Catherine Pellat-Deceunynck
From INSERM U463, Laboratoire Central d'Hématologie, Institut
de Biologie, Service d'Hématologie Clinique, Hôtel-Dieu,
Nantes, France.
Circulating plasma cells in 10 cases of reactive plasmacytosis had a
shared phenotype with early plasma cell (CD19+
CD38+ CD138+ CD40+
CD45+ CD11a+ CD49e
CD56 ). In most cases, a minor subpopulation of
CD28+ plasma cells was also detected. Reactive plasma
cells were highly proliferative, suggesting the presence of circulating
progenitors (plasmablasts). After CD138+ plasma cell
removal, highly proliferative CD138 plasmablasts
differentiated into CD138+ plasma cells within a few
days. This differentiation, which was associated with increased CD38
and decreased HLA-DR expression, was further confirmed by a large
increase in intracellular Ig content (associated with Ig secretion) and
was concomitant with extensive secretion of interleukin-6 (IL-6). The
addition of neutralizing anti-IL-6 and anti-CD126 (IL-6 receptor)
monoclonal antibodies totally prevented Ig secretion and cell
differentiation by inducing apoptosis of plasmablasts, which indicates
that IL-6 is an essential survival factor for plasmablasts. This report
provides the first characterization of normal plasmablasts and shows
that their phenotype is not exactly that of multiple myeloma cells.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Geffroy-Luseau, G. Jego, R. Bataille, L. Campion, and C. Pellat-Deceunynck
Osteoclasts support the survival of human plasma cells in vitro
Int. Immunol.,
June 1, 2008;
20(6):
775 - 782.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Romagnoli, G. Desplanques, S. Maiga, S. Legouill, M. Dreano, R. Bataille, and S. Barille-Nion
Canonical Nuclear Factor {kappa}B Pathway Inhibition Blocks Myeloma Cell Growth and Induces Apoptosis in Strong Synergy with TRAIL
Clin. Cancer Res.,
October 15, 2007;
13(20):
6010 - 6018.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. F. Fecteau, G. Cote, and S. Neron
A New Memory CD27-IgG+ B Cell Population in Peripheral Blood Expressing VH Genes with Low Frequency of Somatic Mutation
J. Immunol.,
September 15, 2006;
177(6):
3728 - 3736.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Menoret, P. Gomez-Bougie, A. Geffroy-Luseau, S. Daniels, P. Moreau, S. Le Gouill, J.-L. Harousseau, R. Bataille, M. Amiot, and C. Pellat-Deceunynck
Mcl-1L cleavage is involved in TRAIL-R1- and TRAIL-R2-mediated apoptosis induced by HGS-ETR1 and HGS-ETR2 human mAbs in myeloma cells
Blood,
August 15, 2006;
108(4):
1346 - 1352.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Gonzalez-Garcia, E. Ocana, G. Jimenez-Gomez, A. Campos-Caro, and J. A. Brieva
Immunization-Induced Perturbation of Human Blood Plasma Cell Pool: Progressive Maturation, IL-6 Responsiveness, and High PRDI-BF1/BLIMP1 Expression Are Critical Distinctions between Antigen-Specific and Nonspecific Plasma Cells
J. Immunol.,
April 1, 2006;
176(7):
4042 - 4050.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Pelletier, M. Casamayor-Palleja, K. De Luca, P. Mondiere, F. Saltel, P. Jurdic, C. Bella, L. Genestier, and T. Defrance
The Endoplasmic Reticulum Is a Key Component of the Plasma Cell Death Pathway
J. Immunol.,
February 1, 2006;
176(3):
1340 - 1347.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Li, P. Hsu, K. Patel, Y. Saffari, I. Ashley, and J. Brody
Polyclonal Plasma Cell Proliferation with Marked Hypergammaglobulinemia and Multiple Autoantibodies
Ann. Clin. Lab. Sci.,
January 1, 2006;
36(4):
479 - 484.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Cepok, B. Rosche, V. Grummel, F. Vogel, D. Zhou, J. Sayn, N. Sommer, H.-P. Hartung, and B. Hemmer
Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis
Brain,
July 1, 2005;
128(7):
1667 - 1676.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Robillard, C. Pellat-Deceunynck, and R. Bataille
Phenotypic characterization of the human myeloma cell growth fraction
Blood,
June 15, 2005;
105(12):
4845 - 4848.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Zwollo, S. Cole, E. Bromage, and S. Kaattari
B Cell Heterogeneity in the Teleost Kidney: Evidence for a Maturation Gradient from Anterior to Posterior Kidney
J. Immunol.,
June 1, 2005;
174(11):
6608 - 6616.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. William, C. Euler, and M. J. Shlomchik
Short-Lived Plasmablasts Dominate the Early Spontaneous Rheumatoid Factor Response: Differentiation Pathways, Hypermutating Cell Types, and Affinity Maturation Outside the Germinal Center
J. Immunol.,
June 1, 2005;
174(11):
6879 - 6887.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. T. Avery, J. I. Ellyard, F. Mackay, L. M. Corcoran, P. D. Hodgkin, and S. G. Tangye
Increased Expression of CD27 on Activated Human Memory B Cells Correlates with Their Commitment to the Plasma Cell Lineage
J. Immunol.,
April 1, 2005;
174(7):
4034 - 4042.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S E Coupland, M Hellmich, C Auw-Haedrich, W R Lee, I Anagnostopoulos, and H Stein
Plasmacellular differentiation in extranodal marginal zone B cell lymphomas of the ocular adnexa: an analysis of the neoplastic plasma cell phenotype and its prognostic significance in 136 cases
Br J Ophthalmol,
March 1, 2005;
89(3):
352 - 359.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Odendahl, H. Mei, B. F. Hoyer, A. M. Jacobi, A. Hansen, G. Muehlinghaus, C. Berek, F. Hiepe, R. Manz, A. Radbruch, et al.
Generation of migratory antigen-specific plasma blasts and mobilization of resident plasma cells in a secondary immune response
Blood,
February 15, 2005;
105(4):
1614 - 1621.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. W.C.J. van de Donk, H. M. Lokhorst, E. H.J. Nijhuis, M. M.J. Kamphuis, and A. C. Bloem
Geranylgeranylated Proteins are Involved in the Regulation of Myeloma Cell Growth
Clin. Cancer Res.,
January 15, 2005;
11(2):
429 - 439.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Riley and C. H. June
The CD28 family: a T-cell rheostat for therapeutic control of T-cell activation
Blood,
January 1, 2005;
105(1):
13 - 21.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. S. Bromage, I. M. Kaattari, P. Zwollo, and S. L. Kaattari
Plasmablast and Plasma Cell Production and Distribution in Trout Immune Tissues
J. Immunol.,
December 15, 2004;
173(12):
7317 - 7323.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. Jaimes, O. L. Rojas, E. J. Kunkel, N. H. Lazarus, D. Soler, E. C. Butcher, D. Bass, J. Angel, M. A. Franco, and H. B. Greenberg
Maturation and Trafficking Markers on Rotavirus-Specific B Cells during Acute Infection and Convalescence in Children
J. Virol.,
October 15, 2004;
78(20):
10967 - 10976.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Tassone, A. Gozzini, V. Goldmacher, M. A. Shammas, K. R. Whiteman, D. R. Carrasco, C. Li, C. K. Allam, S. Venuta, K. C. Anderson, et al.
In Vitro and in Vivo Activity of the Maytansinoid Immunoconjugate huN901-N2'-Deacetyl-N2'-(3-Mercapto-1-Oxopropyl)-Maytansine against CD56+ Multiple Myeloma Cells
Cancer Res.,
July 1, 2004;
64(13):
4629 - 4636.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. I. Ellyard, D. T. Avery, T. G. Phan, N. J. Hare, P. D. Hodgkin, and S. G. Tangye
Antigen-selected, immunoglobulin-secreting cells persist in human spleen and bone marrow
Blood,
May 15, 2004;
103(10):
3805 - 3812.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Matsui, C. A. Huff, Q. Wang, M. T. Malehorn, J. Barber, Y. Tanhehco, B. D. Smith, C. I. Civin, and R. J. Jones
Characterization of clonogenic multiple myeloma cells
Blood,
March 15, 2004;
103(6):
2332 - 2336.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. K. Hoyer, M. Pang, D. Gui, I. P. Shintaku, I. Kuwabara, F.-T. Liu, J. W. Said, L. G. Baum, and M. A. Teitell
An Anti-Apoptotic Role for Galectin-3 in Diffuse Large B-Cell Lymphomas
Am. J. Pathol.,
March 1, 2004;
164(3):
893 - 902.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Ochiai, R. Uchida, S.-i. Fuchida, A. Okano, M. Okamoto, E. Ashihara, T. Inaba, N. Fujita, H. Matsubara, and C. Shimazaki
Effect of farnesyl transferase inhibitor R115777 on the growth of fresh and cloned myeloma cells in vitro
Blood,
November 1, 2003;
102(9):
3349 - 3353.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Tarte, F. Zhan, J. De Vos, B. Klein, and J. Shaughnessy Jr
Gene expression profiling of plasma cells and plasmablasts: toward a better understanding of the late stages of B-cell differentiation
Blood,
July 15, 2003;
102(2):
592 - 600.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F Medina, C Segundo, A Campos-Caro, I Salcedo, A Garcia-Poley, and J A Brieva
Isolation, maturational level, and functional capacity of human colon lamina propria plasma cells
Gut,
March 1, 2003;
52(3):
383 - 389.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Zhan, E. Tian, K. Bumm, R. Smith, B. Barlogie, and J. Shaughnessy Jr
Gene expression profiling of human plasma cell differentiation and classification of multiple myeloma based on similarities to distinct stages of late-stage B-cell development
Blood,
February 1, 2003;
101(3):
1128 - 1140.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K N Potter, C I Mockridge, A Rahman, S Buchan, T Hamblin, B Davidson, D A Isenberg, and F K Stevenson
Disturbances in peripheral blood B cell subpopulations in autoimmune patients
Lupus,
December 1, 2002;
11(12):
872 - 877.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Cerutti, H. Zan, E. C. Kim, S. Shah, E. J. Schattner, A. Schaffer, and P. Casali
Ongoing In Vivo Immunoglobulin Class Switch DNA Recombination in Chronic Lymphocytic Leukemia B Cells
J. Immunol.,
December 1, 2002;
169(11):
6594 - 6603.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. A. M. Wols, G. H. Underhill, G. S. Kansas, and P. L. Witte
The Role of Bone Marrow-Derived Stromal Cells in the Maintenance of Plasma Cell Longevity
J. Immunol.,
October 15, 2002;
169(8):
4213 - 4221.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Tarte, J. De Vos, T. Thykjaer, F. Zhan, G. Fiol, V. Costes, T. Reme, E. Legouffe, J.-F. Rossi, J. Shaughnessy Jr, et al.
Generation of polyclonal plasmablasts from peripheral blood B cells: a normal counterpart of malignant plasmablasts
Blood,
July 30, 2002;
100(4):
1113 - 1122.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. P. O'Connor, M. Cascalho, and R. J. Noelle
Short-lived and Long-lived Bone Marrow Plasma Cells Are Derived from a Novel Precursor Population
J. Exp. Med.,
March 18, 2002;
195(6):
737 - 745.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Medina, C. Segundo, A. Campos-Caro, I. Gonzalez-Garcia, and J. A. Brieva
The heterogeneity shown by human plasma cells from tonsil, blood, and bone marrow reveals graded stages of increasing maturity, but local profiles of adhesion molecule expression
Blood,
March 15, 2002;
99(6):
2154 - 2161.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Arce, D. G. Jackson, M. A. Gill, L. B. Bennett, J. Banchereau, and V. Pascual
Increased Frequency of Pre-germinal Center B Cells and Plasma Cell Precursors in the Blood of Children with Systemic Lupus Erythematosus
J. Immunol.,
August 15, 2001;
167(4):
2361 - 2369.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Jego, R. Bataille, and C. Pellat-Deceunynck
Interleukin-6 is a growth factor for nonmalignant human plasmablasts
Blood,
March 15, 2001;
97(6):
1817 - 1822.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. C. Rawstron, J. A. L. Fenton, J. Ashcroft, A. English, R. A. Jones, S. J. Richards, G. Pratt, R. Owen, F. E. Davies, J. A. Child, et al.
The interleukin-6 receptor alpha-chain (CD126) is expressed by neoplastic but not normal plasma cells
Blood,
December 1, 2000;
96(12):
3880 - 3886.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Sampalo, G. Navas, F. Medina, C. Segundo, C. Camara, and J. A. Brieva
Chronic lymphocytic leukemia B cells inhibit spontaneous Ig production by autologous bone marrow cells: role of CD95-CD95L interaction
Blood,
November 1, 2000;
96(9):
3168 - 3174.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|